Pulmonary hypertension due to myeloproliferative disorders (Q104911): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Knowledge Architect | |||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||
Normal rank | |||
Revision as of 10:46, 17 August 2026
This is an increase of blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, together known as the lung vasculature, leading to shortness of breath, dizziness, fainting, and other symptoms, all of which are exacerbated by exertion, due to myeloproliferative disorders.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1620664579 |
||
| English | Pulmonary hypertension due to myeloproliferative disorders |
This is an increase of blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, together known as the lung vasculature, leading to shortness of breath, dizziness, fainting, and other symptoms, all of which are exacerbated by exertion, due to myeloproliferative disorders. |
Statements
CID11:ID_1620664579
0 references
dki-india-ID_1620664579
0 references
Concluído
0 references
